Vasopressin Improves Outcomes in Cardiac Arrest
Author Information
Author(s): Grmec Stefek, Mally Stefan
Primary Institution: University of Maribor, Maribor, Slovenia
Hypothesis
Vasopressin improves outcome in VF/VT cardiac arrest, especially in patients with acute myocardial infarction (AMI).
Conclusion
The greater 24-hour survival rate in vasopressin-treated patients suggests that combined vasopressin and adrenaline should be considered for treating refractory ventricular fibrillation or pulseless ventricular tachycardia.
Supporting Evidence
- The rates of restoration of spontaneous circulation and subsequent hospital admission were higher in vasopressin-treated groups.
- Higher 24-hour survival rates were observed among vasopressin-treated patients.
- In patients with myocardial infarction, the hospital discharge rate was significantly higher in vasopressin-treated patients.
Takeaway
This study found that using vasopressin during cardiac arrest can help more people survive and leave the hospital, especially if their heart problem was caused by a heart attack.
Methodology
A prospective observational cohort study comparing three treatment groups in a prehospital setting.
Potential Biases
The nonrandomized setting may dilute the value of the conclusions.
Limitations
The study was limited by the small number of patients included and the nonrandomized design.
Participant Demographics
Patients included were adults with nontraumatic cardiac arrest, with similar demographic characteristics across treatment groups.
Statistical Information
P-Value
p<0.01
Confidence Interval
1.5–9.1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website